This study aimed to investigate whether ghrelin affected the autophagy and inflammatory response of intestinal intraepithelial lymphocytes (IELs) by regulating the NOD2/Beclin-1 pathway in an intestinal ischemia–reperfusion (I/R) injury model. Twenty hours after implementing the intestinal I/R injury rat model, the small intestine and both lungs were collected for histological analysis. The morphological changes in the intestinal mucosa epithelium and lung tissues were evaluated using hematoxylin-eosin staining. The activity of autophagic vacuoles and organ injury were evaluated using electron microscopy. The cytokine levels (IL-10 and TNF-α) in IEL cells and lung tissue were determined using enzyme-linked immunosorbent assay. RT-qPCR and western blot assays were conducted to check the NOD2, Beclin-1, and ATG16 levels. Ghrelin relieved the I/R-induced destruction of the intestinal mucosa epithelium and lung tissues. Moreover, ghrelin enhanced autophagy in the intestinal epithelium and lungs of I/R rats. In addition, the levels of autophagy-associated proteins (Beclin-1, ATG16, and NOD2) were higher in the ghrelin treatment group than in rats with I/R. Ghrelin reduced significantly the IL-10 and TNF-α levels. However, these changes were reversed by the NOD2 antagonist. In conclusion, ghrelin may relieve I/R-induced acute intestinal mucosal damage, autophagy disorder, and inflammatory response in IELs by regulating the NOD2/Beclin-1 pathway.
Background The incidence and fatality rate of intestinal I/R injury are increasing year by year, which is a problem that the medical community has been concerned about and needs to be solved urgently. The aim of this study is to explore the effect of the gastrointestinal hormone Ghrelin on the AMPK/FUNDC1 mitophagy pathway under intestinal ischemia and reperfusion, and to clarify the mechanism of the protective effect of Ghrelin on intestinal epithelial cells. Method Adult male SD rats were randomized into four groups: sham surgery (Sham), I/R, I/R + Ghrelin, and I/R + Ghrelin + FUNDC1 antagonist group.A model of intestinal ischemia-reperfusion injury was established by clamped the superior mesenteric artery.Rat intestinal epithelium and lung tissues were taken to observe the histopathological morphology and autophagy activity.To measure the IL-6 test for inflammatory factor levels in intestinal epithelial cells, lung lobes, and peripheral blood by ELISA.The expression levels of autophagy proteins including AMPK, pAMPK, FUNDC1, and LC3 in all the rat intestinal epithelial tissues were determined by Western blot.Intracellular ROS levels were measured by a reactive oxygen species fluorescent probe. Using JC-1 probe to detect mitochondrial membrane potential levels.And the expression was determined by quantitative mtDNA by PCR. Result HE staining showed that there was no significant intestinal mucosal damage in Sham group,while intestinal mucosal damage was evident in I/R group.Similarly,the villus structure in the I/R + group was nearly normal but the structural in the I/R + Ghrelin + FUNDC1 antagonist group was like that in I/R group. Compared with the Sham group, IL-6, ROS, and mtDNA levels were significantly increased while the levels of mitochondrial membrane potential and AMPK, FUNDC1, and LC3 protein expression were decreased in group I/R rats (all P <0.05). Compared with the I/R group, the oxidative stress was reduced in the I/R + Ghrelin group, with improved mitochondrial energy metabolism and increased mitophagy protein expression (all P <0.05).However, the I/R+Ghrelin+FUNDC1 inhibitor group reversed the protective effect of the I/R+Ghrelin group, and the results of each test index were close to the I/R group (all P <0.05). Conclusion: Ghrelin can protect against intestinal ischemia and reperfusion injury and distant organs, which may be regulated by the mitophagy pathway of FUNDC1 by AMPK protein.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.